Osteopontin enhances phagocytosis through a novel osteopontin receptor, the αXβ2 integrin

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 6943-6950

  Schack, Lotte ^a   Stapulionis, Romualdas ^a   Christensen, Brian ^a   Kofod Olsen, Emil ^a   Skov Sørensen, Uffe B ^a   Vorup Jensen, Thomas ^a   Sørensen, Esben S ^a   Höllsberg, Per ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA X BETA 2 INTEGRIN; INTEGRIN; INTERLEUKIN 1; MANGANESE; OSTEOPONTIN; UNCLASSIFIED DRUG; GLYCOPROTEIN P 15095; SPP1 PROTEIN, MOUSE;

ARTICLE; BINDING AFFINITY; CELL ADHESION; CELL MIGRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PURIFICATION; SEROTYPE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; ANIMAL; BINDING SITE; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE; MOUSE MUTANT;

ANIMALS; BINDING SITES; IMMUNITY, INNATE; INTEGRIN ALPHAXBETA2; MICE; MICE, KNOCKOUT; MONOCYTES; OSTEOPONTIN; PHAGOCYTOSIS; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE;

EID: 67449126814     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900065     Document Type: Article

References (49)

1. Sodek, J., B. Ganss, and M. D. McKee. 2000. Osteopontin. Crit. Rev. Oral Biol. Med. 11: 279-303.
2. Patarca, R., G. J. Freeman, R. P. Singh, F. Y. Wei, T. Durfee, F. Blattner, D. C. Regnier, C. A. Kozak, B. A. Mock, H. C. Morse, 3rd, et al. 1989. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene: definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 170: 145-161.
3. Kawamura, K., K. Iyonaga, H. Ichiyasu, J. Nagano, M. Suga, and Y. Sasaki. 2005. Differentiation, maturation, and survival of dendritic cells by osteopontin regulation. Clin. Diagn. Lab. Immunol. 12: 206-212.
4. Sodek, J., A. P. Batista Da Silva, and R. Zohar. 2006. Osteopontin and mucosal protection. J. Dent. Res. 85: 404-415.
5. Rittling, S. R., H. N. Matsumoto, M. D. McKee, A. Nanci, X. R. An, K. E. Novick, A. J. Kowalski, M. Noda, and D. T. Denhardt. 1998. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13: 1101-1111.
6. Nau, G. J., L. Liaw, G. L. Chupp, J. S. Berman, B. L. Hogan, and R. A. Young. 1999. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect. Immun. 67: 4223-4230.
7. Maeno, Y., S. Nakazawa, N. Yamamoto, M. Shinzato, S. Nagashima, K. Tanaka, J. Sasaki, S. R. Rittling, D. T. Denhardt, T. Uede, and K. Taniguchi. 2006. Osteopontin participates in Th1-mediated host resistance against nonlethal malaria parasite Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 74: 2423-2427.
8. Ashkar, S., G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Jansson, S. Zawaideh, S. R. Rittling, D. T. Denhardt, M. J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864.
9. Nau, G. J., P. Guilfoile, G. L. Chupp, J. S. Berman, S. J. Kim, H. Kornfeld, and R. A. Young. 1997. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc. Natl. Acad. Sci. USA 94: 6414-6419.
10. O'Regan, A. W., G. L. Chupp, J. A. Lowry, M. Goetschkes, N. Mulligan, and J. S. Berman. 1999. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J. Immunol. 162: 1024-1031.
11. Sørensen, E. S., P. Højrup, and T. E. Petersen. 1995. Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci. 4: 2040-2049.
12. Christensen, B., M. S. Nielsen, K. F. Haselmann, T. E. Petersen, and E. S. Sørensen. 2005. Posttranslationally modified residues of native human osteopontin are located in clusters: identification of thirty-six phosphorylation and five O-glycosylation sites and their biological implications. Biochem. J. 390: 285-292.
13. Christensen, B., C. C. Kazanecki, T. E. Petersen, S. R. Rittling, D. T. Denhardt, and E. S. Sørensen. 2007. Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J. Biol. Chem. 282: 19463-19472.
14. Weiss, J. M., A. C. Renkl, C. S. Maier, M. Kimmig, L. Liaw, T. Ahrens, S. Kon, M. Maeda, H. Hotta, T. Uede, and J. C. Simon. 2001. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J. Exp. Med. 194: 1219-1229.
15. Koh, A., A. P. da Silva, A. K. Bansal, M. Bansal, C. Sun, H. Lee, M. Glogauer, J. Sodek, and R. Zohar. 2007. Role of osteopontin in neutrophil function. Immunology 122: 466-475.
16. Weber, G. F., S. Zawaideh, S. Hikita, V. A. Kumar, H. Cantor, and S. Ashkar. 2002. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J. Leukocyte Biol. 72: 752-761.
17. Singh, R. P., R. Patarca, J. Schwartz, P. Singh, and H. Cantor. 1990. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J. Exp. Med. 171: 1931-1942.
18. Giachelli, C. M., D. Lombardi, R. J. Johnson, C. E. Murry, and M. Almeida. 1998. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am. J. Pathol. 152: 353-358.
19. Zhu, B., K. Suzuki, H. A. Goldberg, S. R. Rittling, D. T. Denhardt, C. A. McCulloch, and J. Sodek. 2004. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J. Cell. Physiol. 198: 155-167.
20. Nyström, T., P. Dunér, and A. Hultgårdh-Nilsson. 2007. A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Exp. Cell Res. 313: 1149-1160.
21. Yamamoto, N., F. Sakai, S. Kon, J. Morimoto, C. Kimura, H. Yamazaki, I. Okazaki, N. Seki, T. Fujii, and T. Uede. 2003. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J. Clin. Invest. 112: 181-188.
22. Panzer, U., F. Thaiss, G. Zahner, P. Barth, M. Reszka, R. R. Reinking, G. Wolf, U. Helmchen, and R. A. Stahl. 2001. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int. 59: 1762-1769.
23. Okada, H., K. Moriwaki, R. Kalluri, T. Takenaka, H. Imai, S. Ban, M. Takahama, and H. Suzuki. 2000. Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats. Am. J. Physiol. 278: F110-F121.
24. Burdo, T. H., M. R. Wood, and H. S. Fox. 2007. Osteopontin prevents monocyte recirculation and apoptosis. J. Leukocyte Biol. 81: 1504-1511.
25. Liaw, L., D. E. Birk, C. B. Ballas, J. S. Whitsitt, J. M. Davidson, and B. L. Hogan. 1998. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101: 1468-1478. (Pubitemid 28166845)
26. Pedraza, C. E., L. G. Nikolcheva, M. T. Kaartinen, J. E. Barralet, and M. D. McKee. 2008. Osteopontin functions as an opsonin and facilitates phagocytosis by macrophages of hydroxyapatite-coated microspheres: implications for bone wound healing. Bone 43: 708-716.
27. 1 integrin and osteopontin. Biochem. Biophys. Res. Commun. 267: 764-769.
28. 1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol. Biol. Cell. 9: 1425-1435.
29. 3 in smooth muscle cell migration to osteopontin in vitro. J. Clin. Invest. 95: 713-724.
30. 1 to osteopontin. Matrix Biol. 24: 418-427.
31. 1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin. J. Biol. Chem. 276: 13483-13489.
32. 4 integrins. FEBS Lett. 503: 75-79.
33. 1 binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J. Biol. Chem. 274: 36328-36334.
34. 1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 59: 219-226.
35. Weber, G. F., S. Ashkar, M. J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-512.
36. - terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells. Cancer Res. 67: 4088-4097.
37. 2 integrins: moderators of life or death decisions. Trends Immunol. 26: 388-395.
38. Elward, K., and P. Gasque. 2003. "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol. Immunol. 40: 85-94.
39. 2. J. Immunol. 180: 3946-3956.
40. 2. Proc. Natl. Acad. Sci. USA 102: 1614-1619.
41. Kazanecki, C. C., D. J. Uzwiak, and D. T. Denhardt. 2007. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J. Cell. Biochem. 102: 912-924.
42. Sørensen, E. S., and T. E. Petersen. 1993. Purification and characterization of three proteins isolated from the proteose peptone fraction of bovine milk. J. Dairy Res. 60: 189-197.
43. 2 subunit reveals regions that become exposed upon receptor activation. J. Immunol. 166: 5629-5637.
44. Petruzzelli, L., J. Luk, and T.A. Springer. 1995. Adhesion structure subpanel 5, leukocyte integrins: CD11a, CD11b, CD11c, CD18. In Leucocyte Typing V: White Cell Differentiation Antigens. S. F. Schlossman, L. Boumsell, W. Gilks, J. Harlan, T. Kishimoto, T. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, et al., eds. Oxford Univ. Press, New York, pp. 1581-1585.
45. Weetall, M., R. Hugo, C. Friedman, S. Maida, S. West, S. Wattanasin, R. Bouhel, G. Weitz-Schmidt, and P. Lake. 2001. A homogeneous fluorometric assay for measuring cell adhesion to immobilized ligand using V-well microtiter plates. Anal. Biochem. 293: 277-287.
46. Robinson, M. K., D. Andrew, H. Rosen, D. Brown, S. Ortlepp, P. Stephens, and E. C. Butcher. 1992. Antibody against the Leu-CAM β-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. J. Immunol. 148: 1080-1085.
47. Beletskii, A., M. Cooper, P. Sriraman, C. Chiriac, L. Zhao, S. Abbot, and L. Yu. 2005. High-throughput phagocytosis assay utilizing a pH-sensitive fluorescent dye. Biotechniques 39: 894-897.
48. Heilmann, K., U. Hoffmann, E. Witte, C. Loddenkemper, C. Sina, S. Schreiber, C. Hayford, P. Holzlohner, K. Wolk, E. Tchatchou, et al. 2008. Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol. Med. Epub ahead of print on July 8; DOI: 10.1111/j.1582-4934.2008.00428.x.
49. Marcondes, M. C., M. Poling, D. D. Watry, D. Hall, and H. S. Fox. 2008. In vivo osteopontin-induced macrophage accumulation is dependent on CD44 expression. Cell. Immunol. 254: 56-62.